• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Primary amines

Introduction to 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride (CAS No. 105773-99-7)

5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride (CAS No. 105773-99-7) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as AETD, is a derivative of thiazole and has gained attention due to its potential therapeutic properties and its role in the development of novel drugs.

The chemical structure of 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride is characterized by a thiazole ring linked to an aminoethyl group, which is further substituted with an amine functional group. The presence of these functional groups imparts unique chemical and biological properties to the molecule, making it a valuable candidate for various research applications.

In recent years, significant advancements have been made in understanding the biological activities of 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride. Studies have shown that this compound exhibits potent antiviral and antimicrobial properties, making it a promising candidate for the development of new therapeutic agents. For instance, a study published in the Journal of Medicinal Chemistry in 2021 reported that AETD demonstrated strong inhibitory effects against several strains of viruses and bacteria, including drug-resistant strains.

Beyond its antiviral and antimicrobial activities, 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride has also been investigated for its potential as a neuroprotective agent. Research conducted at the University of California, San Francisco, revealed that AETD can effectively reduce neuronal damage in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The mechanism behind this neuroprotective effect is believed to involve the modulation of oxidative stress and inflammation pathways.

The pharmacokinetic properties of 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride have also been extensively studied. Data from preclinical trials indicate that AETD has favorable absorption, distribution, metabolism, and excretion (ADME) profiles. These properties make it suitable for both oral and parenteral administration, enhancing its potential as a therapeutic agent.

In addition to its therapeutic applications, 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride has been used as a building block in the synthesis of more complex molecules. Its reactive functional groups allow for easy modification and functionalization, enabling chemists to create derivatives with tailored properties. This versatility has led to its use in the development of novel drug candidates and materials with enhanced biological activity.

The safety profile of 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride has been evaluated through various toxicological studies. Results from these studies suggest that AETD is generally well-tolerated at therapeutic doses, with minimal side effects observed in animal models. However, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

The potential applications of 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride extend beyond medicinal chemistry. In the field of materials science, this compound has been explored for its ability to form stable complexes with metal ions. These complexes have shown promise in catalytic reactions and as components in advanced materials such as sensors and coatings.

In conclusion, 5-(2-aminoethyl)-1,3-thiazol-2-amine dihydrochloride (CAS No. 105773-99-7), or AETD, is a multifaceted compound with a wide range of applications in medicinal chemistry, pharmaceutical research, and materials science. Its unique chemical structure and biological activities make it a valuable tool for scientists and researchers working on the development of new therapeutic agents and advanced materials. As research continues to uncover new properties and applications of this compound, it is likely to play an increasingly important role in various scientific disciplines.

• 39136-60-2(5-Ethylthiazol-2-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)